auc Search Results


gc fame analysis  (Avanti Polar)
90
Avanti Polar gc fame analysis
Gc Fame Analysis, supplied by Avanti Polar, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gc fame analysis/product/Avanti Polar
Average 90 stars, based on 1 article reviews
gc fame analysis - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier
analytical ultracentrifuge  (Beckman Coulter)
96
Beckman Coulter analytical ultracentrifuge
Analytical Ultracentrifuge, supplied by Beckman Coulter, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/analytical ultracentrifuge/product/Beckman Coulter
Average 96 stars, based on 1 article reviews
analytical ultracentrifuge - by Bioz Stars, 2026-06
96/100 stars
  Buy from Supplier
auc-type statistic  (Schmid GmbH)
90
Schmid GmbH auc-type statistic
Auc Type Statistic, supplied by Schmid GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/auc-type statistic/product/Schmid GmbH
Average 90 stars, based on 1 article reviews
auc-type statistic - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier
auc  (Kirstein GmbH)
90
Kirstein GmbH auc
Auc, supplied by Kirstein GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/auc/product/Kirstein GmbH
Average 90 stars, based on 1 article reviews
auc - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier
auc values  (NeuroVista Corporation)
90
NeuroVista Corporation auc values
Auc Values, supplied by NeuroVista Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/auc values/product/NeuroVista Corporation
Average 90 stars, based on 1 article reviews
auc values - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier
auc of the nrs scores  (GraphPad Software Inc)
90
GraphPad Software Inc auc of the nrs scores
Auc Of The Nrs Scores, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/auc of the nrs scores/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
auc of the nrs scores - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier
auc (0–12)  (Bayer AG)
90
Bayer AG auc (0–12)
Auc (0–12), supplied by Bayer AG, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/auc (0–12)/product/Bayer AG
Average 90 stars, based on 1 article reviews
auc (0–12) - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier
niclosamide elf c max and auc  (NEN Life Science)
90
NEN Life Science niclosamide elf c max and auc
Pharmacokinetics <t>of</t> <t>niclosamide</t> following nebulization in sheep. A Time-course profile of plasma concentration of niclosamide following nebulization of 0.167%, 0.5% and 1% niclosamide ethanolamine (NEN) solution and 0.1% NEN solution via intravenous administration on linear (left panel) and semilog scale (right panel). Eight datapoints from individual sheep were excluded in non-compartmental analysis and are not shown here as they could not be explained by protocol deviation and disagreed with basic pharmacokinetic principles but are displayed in Fig. in the supplementary information. B Pearson correlation of mean plasma C max of the three nebulized doses of this study to mean plasma C max of dose-matched cohorts of Phase 1 trial by Backer et al. . r = pearson correlation coefficient. Mean ± SEM displayed. C Time-course profile of niclosamide concentration in epithelial lining fluid (ELF) as combined profile following 0.167% ,0.5% and 1% NEN nebulized administration on linear scale. D Area-under the curve <t>(AUC)</t> and maximum concentration (C max ) of niclosamide in ELF following nebulized NEN versus the human equivalent 2 g oral dose (corresponding to 1132 mg niclosamide). For panel A , C , D mean ± SEM is displayed, and data is from n=5 sheep per group. LLOQ = lower limit of quantification.
Niclosamide Elf C Max And Auc, supplied by NEN Life Science, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/niclosamide elf c max and auc/product/NEN Life Science
Average 90 stars, based on 1 article reviews
niclosamide elf c max and auc - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier
auc calculation  (GraphPad Software Inc)
90
GraphPad Software Inc auc calculation
Pharmacokinetics <t>of</t> <t>niclosamide</t> following nebulization in sheep. A Time-course profile of plasma concentration of niclosamide following nebulization of 0.167%, 0.5% and 1% niclosamide ethanolamine (NEN) solution and 0.1% NEN solution via intravenous administration on linear (left panel) and semilog scale (right panel). Eight datapoints from individual sheep were excluded in non-compartmental analysis and are not shown here as they could not be explained by protocol deviation and disagreed with basic pharmacokinetic principles but are displayed in Fig. in the supplementary information. B Pearson correlation of mean plasma C max of the three nebulized doses of this study to mean plasma C max of dose-matched cohorts of Phase 1 trial by Backer et al. . r = pearson correlation coefficient. Mean ± SEM displayed. C Time-course profile of niclosamide concentration in epithelial lining fluid (ELF) as combined profile following 0.167% ,0.5% and 1% NEN nebulized administration on linear scale. D Area-under the curve <t>(AUC)</t> and maximum concentration (C max ) of niclosamide in ELF following nebulized NEN versus the human equivalent 2 g oral dose (corresponding to 1132 mg niclosamide). For panel A , C , D mean ± SEM is displayed, and data is from n=5 sheep per group. LLOQ = lower limit of quantification.
Auc Calculation, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/auc calculation/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
auc calculation - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier
auc with graphpad prism 7.0  (GraphPad Software Inc)
90
GraphPad Software Inc auc with graphpad prism 7.0
Pharmacokinetics <t>of</t> <t>niclosamide</t> following nebulization in sheep. A Time-course profile of plasma concentration of niclosamide following nebulization of 0.167%, 0.5% and 1% niclosamide ethanolamine (NEN) solution and 0.1% NEN solution via intravenous administration on linear (left panel) and semilog scale (right panel). Eight datapoints from individual sheep were excluded in non-compartmental analysis and are not shown here as they could not be explained by protocol deviation and disagreed with basic pharmacokinetic principles but are displayed in Fig. in the supplementary information. B Pearson correlation of mean plasma C max of the three nebulized doses of this study to mean plasma C max of dose-matched cohorts of Phase 1 trial by Backer et al. . r = pearson correlation coefficient. Mean ± SEM displayed. C Time-course profile of niclosamide concentration in epithelial lining fluid (ELF) as combined profile following 0.167% ,0.5% and 1% NEN nebulized administration on linear scale. D Area-under the curve <t>(AUC)</t> and maximum concentration (C max ) of niclosamide in ELF following nebulized NEN versus the human equivalent 2 g oral dose (corresponding to 1132 mg niclosamide). For panel A , C , D mean ± SEM is displayed, and data is from n=5 sheep per group. LLOQ = lower limit of quantification.
Auc With Graphpad Prism 7.0, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/auc with graphpad prism 7.0/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
auc with graphpad prism 7.0 - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier
roc curves and auc  (GraphPad Software Inc)
90
GraphPad Software Inc roc curves and auc
Pharmacokinetics <t>of</t> <t>niclosamide</t> following nebulization in sheep. A Time-course profile of plasma concentration of niclosamide following nebulization of 0.167%, 0.5% and 1% niclosamide ethanolamine (NEN) solution and 0.1% NEN solution via intravenous administration on linear (left panel) and semilog scale (right panel). Eight datapoints from individual sheep were excluded in non-compartmental analysis and are not shown here as they could not be explained by protocol deviation and disagreed with basic pharmacokinetic principles but are displayed in Fig. in the supplementary information. B Pearson correlation of mean plasma C max of the three nebulized doses of this study to mean plasma C max of dose-matched cohorts of Phase 1 trial by Backer et al. . r = pearson correlation coefficient. Mean ± SEM displayed. C Time-course profile of niclosamide concentration in epithelial lining fluid (ELF) as combined profile following 0.167% ,0.5% and 1% NEN nebulized administration on linear scale. D Area-under the curve <t>(AUC)</t> and maximum concentration (C max ) of niclosamide in ELF following nebulized NEN versus the human equivalent 2 g oral dose (corresponding to 1132 mg niclosamide). For panel A , C , D mean ± SEM is displayed, and data is from n=5 sheep per group. LLOQ = lower limit of quantification.
Roc Curves And Auc, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/roc curves and auc/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
roc curves and auc - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier
auc  (GraphPad Software Inc)
90
GraphPad Software Inc auc
Pharmacokinetics <t>of</t> <t>niclosamide</t> following nebulization in sheep. A Time-course profile of plasma concentration of niclosamide following nebulization of 0.167%, 0.5% and 1% niclosamide ethanolamine (NEN) solution and 0.1% NEN solution via intravenous administration on linear (left panel) and semilog scale (right panel). Eight datapoints from individual sheep were excluded in non-compartmental analysis and are not shown here as they could not be explained by protocol deviation and disagreed with basic pharmacokinetic principles but are displayed in Fig. in the supplementary information. B Pearson correlation of mean plasma C max of the three nebulized doses of this study to mean plasma C max of dose-matched cohorts of Phase 1 trial by Backer et al. . r = pearson correlation coefficient. Mean ± SEM displayed. C Time-course profile of niclosamide concentration in epithelial lining fluid (ELF) as combined profile following 0.167% ,0.5% and 1% NEN nebulized administration on linear scale. D Area-under the curve <t>(AUC)</t> and maximum concentration (C max ) of niclosamide in ELF following nebulized NEN versus the human equivalent 2 g oral dose (corresponding to 1132 mg niclosamide). For panel A , C , D mean ± SEM is displayed, and data is from n=5 sheep per group. LLOQ = lower limit of quantification.
Auc, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/auc/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
auc - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

Image Search Results


Pharmacokinetics of niclosamide following nebulization in sheep. A Time-course profile of plasma concentration of niclosamide following nebulization of 0.167%, 0.5% and 1% niclosamide ethanolamine (NEN) solution and 0.1% NEN solution via intravenous administration on linear (left panel) and semilog scale (right panel). Eight datapoints from individual sheep were excluded in non-compartmental analysis and are not shown here as they could not be explained by protocol deviation and disagreed with basic pharmacokinetic principles but are displayed in Fig. in the supplementary information. B Pearson correlation of mean plasma C max of the three nebulized doses of this study to mean plasma C max of dose-matched cohorts of Phase 1 trial by Backer et al. . r = pearson correlation coefficient. Mean ± SEM displayed. C Time-course profile of niclosamide concentration in epithelial lining fluid (ELF) as combined profile following 0.167% ,0.5% and 1% NEN nebulized administration on linear scale. D Area-under the curve (AUC) and maximum concentration (C max ) of niclosamide in ELF following nebulized NEN versus the human equivalent 2 g oral dose (corresponding to 1132 mg niclosamide). For panel A , C , D mean ± SEM is displayed, and data is from n=5 sheep per group. LLOQ = lower limit of quantification.

Journal: Pharmaceutical Research

Article Title: Single-dose pharmacokinetics and lung function of nebulized niclosamide ethanolamine in sheep

doi: 10.1007/s11095-023-03559-0

Figure Lengend Snippet: Pharmacokinetics of niclosamide following nebulization in sheep. A Time-course profile of plasma concentration of niclosamide following nebulization of 0.167%, 0.5% and 1% niclosamide ethanolamine (NEN) solution and 0.1% NEN solution via intravenous administration on linear (left panel) and semilog scale (right panel). Eight datapoints from individual sheep were excluded in non-compartmental analysis and are not shown here as they could not be explained by protocol deviation and disagreed with basic pharmacokinetic principles but are displayed in Fig. in the supplementary information. B Pearson correlation of mean plasma C max of the three nebulized doses of this study to mean plasma C max of dose-matched cohorts of Phase 1 trial by Backer et al. . r = pearson correlation coefficient. Mean ± SEM displayed. C Time-course profile of niclosamide concentration in epithelial lining fluid (ELF) as combined profile following 0.167% ,0.5% and 1% NEN nebulized administration on linear scale. D Area-under the curve (AUC) and maximum concentration (C max ) of niclosamide in ELF following nebulized NEN versus the human equivalent 2 g oral dose (corresponding to 1132 mg niclosamide). For panel A , C , D mean ± SEM is displayed, and data is from n=5 sheep per group. LLOQ = lower limit of quantification.

Article Snippet: Niclosamide ELF C max and AUC was substantially higher compared to plasma following nebulization, with a partition coefficient Kp ELF:Plasma remaining high over time (Table ); Kp was approximately at 70 (5 min) and 122 (1-2 h) (1% NEN plasma data used for calculation).

Techniques: Drug discovery, Clinical Proteomics, Concentration Assay

Non-Compartmental pharmacokinetic parameters of niclosamide in plasma and epithelial lining fluid (ELF) following nebulization and oral administration. Absorption rate constant (k α ) and bioavailability (F) were estimated by population pharmacokinetic modeling. Full list of the parameter estimates of the population pharmacokinetic model for nebulized niclosamide are displayed in Table S2.

Journal: Pharmaceutical Research

Article Title: Single-dose pharmacokinetics and lung function of nebulized niclosamide ethanolamine in sheep

doi: 10.1007/s11095-023-03559-0

Figure Lengend Snippet: Non-Compartmental pharmacokinetic parameters of niclosamide in plasma and epithelial lining fluid (ELF) following nebulization and oral administration. Absorption rate constant (k α ) and bioavailability (F) were estimated by population pharmacokinetic modeling. Full list of the parameter estimates of the population pharmacokinetic model for nebulized niclosamide are displayed in Table S2.

Article Snippet: Niclosamide ELF C max and AUC was substantially higher compared to plasma following nebulization, with a partition coefficient Kp ELF:Plasma remaining high over time (Table ); Kp was approximately at 70 (5 min) and 122 (1-2 h) (1% NEN plasma data used for calculation).

Techniques: Clinical Proteomics